Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Rite Aid Stock Has a Lot to Prove on Thursday
Rite Aid Stock Has a Lot to Prove on Thursday
Regulators finally gave Rite Aid (NYSE: RAD) clearance for an asset sale last week, but it's apparently a case of "too little, too late" for investors who have seen the drugstore operator get....
Rite Aid Stock Has a Lot to Prove on Thursday
Rite Aid Stock Has a Lot to Prove on Thursday
Regulators finally gave Rite Aid (NYSE: RAD) clearance for an asset sale last week, but it's apparently a case of "too little, too late" for investors who have seen the drugstore operator get....
Rite Aid Stock Has a Lot to Prove on Thursday
Rite Aid Stock Has a Lot to Prove on Thursday
Regulators finally gave Rite Aid (NYSE: RAD) clearance for an asset sale last week, but it's apparently a case of "too little, too late" for investors who have seen the drugstore operator get....
Rite Aid Stock Has a Lot to Prove on Thursday
Rite Aid Stock Has a Lot to Prove on Thursday
Regulators finally gave Rite Aid (NYSE: RAD) clearance for an asset sale last week, but it's apparently a case of "too little, too late" for investors who have seen the drugstore operator get....
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
If you've ever wondered why drugmakers run Phase I-II or II B clinical trials, how drugmakers like AbbVie (NYSE: ABBV) plan on keeping generic drugmakers at bay after their patents expire, or why....
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
If you've ever wondered why drugmakers run Phase I-II or II B clinical trials, how drugmakers like AbbVie (NYSE: ABBV) plan on keeping generic drugmakers at bay after their patents expire, or why....
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
If you've ever wondered why drugmakers run Phase I-II or II B clinical trials, how drugmakers like AbbVie (NYSE: ABBV) plan on keeping generic drugmakers at bay after their patents expire, or why....
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
Ask a Fool! We Answer Your Healthcare Questions on Trials, Patents, and Pharmacy Retailers
If you've ever wondered why drugmakers run Phase I-II or II B clinical trials, how drugmakers like AbbVie (NYSE: ABBV) plan on keeping generic drugmakers at bay after their patents expire, or why....
Should You Buy Rite Aid Stock Now That the Walgreens Deal Is Done?
Should You Buy Rite Aid Stock Now That the Walgreens Deal Is Done?
Like the series finale of a long-running TV drama, the final act in the deal between Rite Aid Corporation (NYSE: RAD) and Walgreens Boots Alliance (NASDAQ: WBA) had one last plot twist.The U.S.....
Should You Buy Rite Aid Stock Now That the Walgreens Deal Is Done?
Should You Buy Rite Aid Stock Now That the Walgreens Deal Is Done?
Like the series finale of a long-running TV drama, the final act in the deal between Rite Aid Corporation (NYSE: RAD) and Walgreens Boots Alliance (NASDAQ: WBA) had one last plot twist.The U.S.....
Should You Buy Rite Aid Stock Now That the Walgreens Deal Is Done?
Should You Buy Rite Aid Stock Now That the Walgreens Deal Is Done?
Like the series finale of a long-running TV drama, the final act in the deal between Rite Aid Corporation (NYSE: RAD) and Walgreens Boots Alliance (NASDAQ: WBA) had one last plot twist.The U.S.....
Should You Buy Rite Aid Stock Now That the Walgreens Deal Is Done?
Should You Buy Rite Aid Stock Now That the Walgreens Deal Is Done?
Like the series finale of a long-running TV drama, the final act in the deal between Rite Aid Corporation (NYSE: RAD) and Walgreens Boots Alliance (NASDAQ: WBA) had one last plot twist.The U.S.....
With Its Amazon Deal, Kohl's Is Playing With Fire
With Its Amazon Deal, Kohl's Is Playing With Fire
Amazon.com (NASDAQ: AMZN) is no friend to brick-and-mortar retailers. The e-commerce giant's breakneck growth and speedy delivery has put dozens of traditional retailers out of business and is....
With Its Amazon Deal, Kohl's Is Playing With Fire
With Its Amazon Deal, Kohl's Is Playing With Fire
Amazon.com (NASDAQ: AMZN) is no friend to brick-and-mortar retailers. The e-commerce giant's breakneck growth and speedy delivery has put dozens of traditional retailers out of business and is....
Rite Aid (Finally!) Gets OK to Sell Stores to Walgreens
Rite Aid (Finally!) Gets OK to Sell Stores to Walgreens
Only months after Rite Aid's (NYSE: RAD) planned merger with Walgreens Boots Alliance (NASDAQ: WBA) fell apart, the two companies have successfully convinced regulators to OK a smaller deal in....
Rite Aid (Finally!) Gets OK to Sell Stores to Walgreens
Rite Aid (Finally!) Gets OK to Sell Stores to Walgreens
Only months after Rite Aid's (NYSE: RAD) planned merger with Walgreens Boots Alliance (NASDAQ: WBA) fell apart, the two companies have successfully convinced regulators to OK a smaller deal in....
Rite Aid (Finally!) Gets OK to Sell Stores to Walgreens
Rite Aid (Finally!) Gets OK to Sell Stores to Walgreens
Only months after Rite Aid's (NYSE: RAD) planned merger with Walgreens Boots Alliance (NASDAQ: WBA) fell apart, the two companies have successfully convinced regulators to OK a smaller deal in....
Rite Aid (Finally!) Gets OK to Sell Stores to Walgreens
Rite Aid (Finally!) Gets OK to Sell Stores to Walgreens
Only months after Rite Aid's (NYSE: RAD) planned merger with Walgreens Boots Alliance (NASDAQ: WBA) fell apart, the two companies have successfully convinced regulators to OK a smaller deal in....
Why Rite Aid Corporation Stock Tumbled Today
Why Rite Aid Corporation Stock Tumbled Today
Shares of Rite Aid Corporation (NYSE: RAD) took a dive today after the company's agreement to sell a chunk of its stores to Walgreens Boots Alliance (NASDAQ: WBA) was finally approved by the....
Why Rite Aid Corporation Stock Tumbled Today
Why Rite Aid Corporation Stock Tumbled Today
Shares of Rite Aid Corporation (NYSE: RAD) took a dive today after the company's agreement to sell a chunk of its stores to Walgreens Boots Alliance (NASDAQ: WBA) was finally approved by the....
Why Rite Aid Corporation Stock Tumbled Today
Why Rite Aid Corporation Stock Tumbled Today
Shares of Rite Aid Corporation (NYSE: RAD) took a dive today after the company's agreement to sell a chunk of its stores to Walgreens Boots Alliance (NASDAQ: WBA) was finally approved by the....
Why Rite Aid Corporation Stock Tumbled Today
Why Rite Aid Corporation Stock Tumbled Today
Shares of Rite Aid Corporation (NYSE: RAD) took a dive today after the company's agreement to sell a chunk of its stores to Walgreens Boots Alliance (NASDAQ: WBA) was finally approved by the....
3 Must-Watch Stocks Heading Into Earnings Season
3 Must-Watch Stocks Heading Into Earnings Season
The quiet summer months are over, and the financial markets have gotten back to work after a quiet yet profitable period for stock investors. Now, your attention should turn to earnings reports....
3 Must-Watch Stocks Heading Into Earnings Season
3 Must-Watch Stocks Heading Into Earnings Season
The quiet summer months are over, and the financial markets have gotten back to work after a quiet yet profitable period for stock investors. Now, your attention should turn to earnings reports....
3 Must-Watch Stocks Heading Into Earnings Season
3 Must-Watch Stocks Heading Into Earnings Season
The quiet summer months are over, and the financial markets have gotten back to work after a quiet yet profitable period for stock investors. Now, your attention should turn to earnings reports....